Impact of Injection Speed, Volume, and Site on Pain Sensation
- PMID: 28990437
- PMCID: PMC5761988
- DOI: 10.1177/1932296817735121
Impact of Injection Speed, Volume, and Site on Pain Sensation
Abstract
Background: Painful subcutaneous insulin injections may decrease treatment compliance. Improving injection comfort therefore represents a particular area of technological research in which steady progress has been made since the introduction of the insulin pen in 1985. Injection pain can be influenced by many variables, but relatively little is known about their impact. This study investigated the impact of injection volume (range 0-2250 µL), speed (range 0-800 µL/sec), and site (abdomen vs thigh) on pain sensation.
Method: In random order, patients (n = 80) with type 1 or type 2 diabetes received 24 saline injections subcutaneously through a 27G ultra-thin-wall needle. Injections were performed in the abdomen (n = 19) and thigh (n = 5) with predefined speed-volume combinations. For each injected speed-volume combination, patients scored their pain sensation on a 100 mm visual analog scale (VAS).
Results: The mean pain scores for speed-volume combinations were all in the lower part (<20 mm) of the VAS, indicating zero to mild pain. Pain sensation was statistically higher ( P < .05) with the 2250 µL volume compared to other injection volumes (range 4.3-5.1 mm) and with thigh compared to abdomen injections (2.1 mm). Pain sensation did not change with increasing injection speed. Patient acceptance of the injection pain was high for all injections (range 93.7-98.7%).
Conclusions: In summary, large volume and thigh injections are rated more painful, but the clinical impact of these findings is likely marginal considering the low absolute pain levels and high patient acceptance rates. Injection speed does not influence pain sensation.
Keywords: diabetes; dosing accuracy; injection pain; insulin pen; subcutaneous injection.
Conflict of interest statement
Figures
Similar articles
-
Impact of injection speed and volume on perceived pain during subcutaneous injections into the abdomen and thigh: a single-centre, randomized controlled trial.Diabetes Obes Metab. 2014 Oct;16(10):971-6. doi: 10.1111/dom.12304. Epub 2014 May 11. Diabetes Obes Metab. 2014. PMID: 24720741 Clinical Trial.
-
Subcutaneous Injection of Drugs: Literature Review of Factors Influencing Pain Sensation at the Injection Site.Adv Ther. 2019 Nov;36(11):2986-2996. doi: 10.1007/s12325-019-01101-6. Epub 2019 Oct 5. Adv Ther. 2019. PMID: 31587143 Free PMC article. Review.
-
A Phase I Study to Assess the Effect of Speed of Injection on Pain, Tolerability, and Pharmacokinetics After High-volume Subcutaneous Administration of Gantenerumab in Healthy Volunteers.Clin Ther. 2020 Jan;42(1):108-120.e1. doi: 10.1016/j.clinthera.2019.11.015. Epub 2019 Dec 26. Clin Ther. 2020. PMID: 31883703 Clinical Trial.
-
A comparison of insulin injection needles on patients' perceptions of pain, handling, and acceptability: a randomized, open-label, crossover study in subjects with diabetes.Diabetes Technol Ther. 2009 Mar;11(3):195-201. doi: 10.1089/dia.2008.0054. Diabetes Technol Ther. 2009. PMID: 19267582 Clinical Trial.
-
Subcutaneous Injection Volume of Biopharmaceuticals-Pushing the Boundaries.J Pharm Sci. 2016 Aug;105(8):2255-9. doi: 10.1016/j.xphs.2016.05.029. Epub 2016 Jul 1. J Pharm Sci. 2016. PMID: 27378678 Review.
Cited by
-
The how's and what's of vaccine reactogenicity.NPJ Vaccines. 2019 Sep 24;4:39. doi: 10.1038/s41541-019-0132-6. eCollection 2019. NPJ Vaccines. 2019. PMID: 31583123 Free PMC article. Review.
-
Customized Heparinized Alginate and Collagen Hydrogels for Tunable, Local Delivery of Angiogenic Proteins.ACS Biomater Sci Eng. 2025 Mar 10;11(3):1612-1628. doi: 10.1021/acsbiomaterials.4c01823. Epub 2025 Feb 13. ACS Biomater Sci Eng. 2025. PMID: 39945764
-
Gonadotropin-releasing hormone analog therapies for children with central precocious puberty in the United States.Front Pediatr. 2022 Oct 4;10:968485. doi: 10.3389/fped.2022.968485. eCollection 2022. Front Pediatr. 2022. PMID: 36268040 Free PMC article. Review.
-
Injectable Lipid-Based Depot Formulations: Where Do We Stand?Pharmaceutics. 2020 Jun 19;12(6):567. doi: 10.3390/pharmaceutics12060567. Pharmaceutics. 2020. PMID: 32575406 Free PMC article. Review.
-
Vasodilatory effects of glucagon: A possible new approach to enhanced subcutaneous insulin absorption in artificial pancreas devices.Front Bioeng Biotechnol. 2022 Sep 21;10:986858. doi: 10.3389/fbioe.2022.986858. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36213069 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical